Rankings
▼
Calendar
GPCR FY 2023 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$103M
Net Income
-$90M
EPS (Diluted)
$-2.43
Cash Flow
Operating Cash Flow
-$79M
Free Cash Flow
-$82M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$482M
Total Liabilities
$29M
Stockholders' Equity
$453M
Cash & Equivalents
$130M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$103M
-$53M
-95.5%
Net Income
-$90M
-$51M
-74.6%
← Q4 2022
All Quarters
Q1 2023 →